# Microchip Technology Inc: financial statements, quarterly

MCHP · Nasdaq · CIK 827054 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/mchp.md) · [Financials](/companies/mchp/financials.md) · [Filings](/companies/mchp/filings.md) · [Insiders](/companies/mchp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mchp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,254](/filings/0000827054-24-000206.md) | [1,766](/filings/0000827054-25-000019.md) | [1,326 d](/filings/0000827054-26-000016.md) | [1,241](/filings/0000827054-25-000133.md) | [1,164](/filings/0000827054-25-000183.md) | [1,026](/filings/0000827054-26-000009.md) | [971 d](/filings/0000827054-26-000016.md) | [1,076](/filings/0000827054-26-000038.md) | [1,140](/filings/0000827054-25-000183.md) | [1,186](/filings/0000827054-26-000009.md) | [1,311 d](/filings/0000827054-26-000016.md) | [1,485](/filings/0000827054-26-000038.md) |
| Cost of revenue | $m | [727](/filings/0000827054-24-000206.md) | [646](/filings/0000827054-25-000019.md) | [536 d](/filings/0000827054-26-000016.md) | [504](/filings/0000827054-25-000133.md) | [495](/filings/0000827054-25-000183.md) | [465](/filings/0000827054-26-000009.md) | [469 d](/filings/0000827054-26-000016.md) | [499](/filings/0000827054-26-000038.md) | [503](/filings/0000827054-25-000183.md) | [479](/filings/0000827054-26-000009.md) | [512 d](/filings/0000827054-26-000016.md) | [546](/filings/0000827054-26-000038.md) |
| Gross profit | $m | [1,527](/filings/0000827054-24-000206.md) | [1,120](/filings/0000827054-25-000019.md) | [790 d](/filings/0000827054-26-000016.md) | [737](/filings/0000827054-25-000133.md) | [669](/filings/0000827054-25-000183.md) | [561](/filings/0000827054-26-000009.md) | [501 d](/filings/0000827054-26-000016.md) | [577](/filings/0000827054-26-000038.md) | [638](/filings/0000827054-25-000183.md) | [707](/filings/0000827054-26-000009.md) | [800 d](/filings/0000827054-26-000016.md) | [939](/filings/0000827054-26-000038.md) |
| Research and development | $m | [293](/filings/0000827054-24-000206.md) | [266](/filings/0000827054-25-000019.md) | [240 d](/filings/0000827054-26-000016.md) | [242](/filings/0000827054-25-000133.md) | [241](/filings/0000827054-25-000183.md) | [246](/filings/0000827054-26-000009.md) | [255 d](/filings/0000827054-26-000016.md) | [256](/filings/0000827054-26-000038.md) | [262](/filings/0000827054-25-000183.md) | [274](/filings/0000827054-26-000009.md) | [294 d](/filings/0000827054-26-000016.md) | [309](/filings/0000827054-26-000038.md) |
| Selling, general and administrative | $m | [197](/filings/0000827054-24-000206.md) | [172](/filings/0000827054-25-000019.md) | [162 d](/filings/0000827054-26-000016.md) | [151](/filings/0000827054-25-000133.md) | [157](/filings/0000827054-25-000183.md) | [158](/filings/0000827054-26-000009.md) | [152 d](/filings/0000827054-26-000016.md) | [159](/filings/0000827054-26-000038.md) | [172](/filings/0000827054-25-000183.md) | [169](/filings/0000827054-26-000009.md) | [174 d](/filings/0000827054-26-000016.md) | [184](/filings/0000827054-26-000038.md) |
| Operating income | $m | [885](/filings/0000827054-24-000206.md) | [529](/filings/0000827054-25-000019.md) | [254 d](/filings/0000827054-26-000016.md) | [219](/filings/0000827054-25-000133.md) | [147](/filings/0000827054-25-000183.md) | [30.9](/filings/0000827054-26-000009.md) | [(100) d](/filings/0000827054-26-000016.md) | [32.1](/filings/0000827054-26-000038.md) | [88.9](/filings/0000827054-25-000183.md) | [152](/filings/0000827054-26-000009.md) | [217 d](/filings/0000827054-26-000016.md) | [337](/filings/0000827054-26-000038.md) |
| Interest expense | $m | [46.8](/filings/0000827054-24-000206.md) | [49.2](/filings/0000827054-24-000024.md) | [55.1 d](/filings/0000827054-24-000098.md) | [61.8](/filings/0000827054-24-000139.md) | [59.1](/filings/0000827054-24-000206.md) | [68.7](/filings/0000827054-26-000009.md) | [69.6 d](/filings/0000827054-26-000016.md) | [57.4](/filings/0000827054-26-000038.md) | [56.3](/filings/0000827054-25-000183.md) | [55.9](/filings/0000827054-26-000009.md) | [51.7 d](/filings/0000827054-26-000016.md) | [48.8](/filings/0000827054-26-000038.md) |
| Income tax | $m | [167](/filings/0000827054-24-000206.md) | [65.1](/filings/0000827054-25-000019.md) | [45.0 d](/filings/0000827054-26-000016.md) | [32.5](/filings/0000827054-25-000133.md) | [13.1](/filings/0000827054-25-000183.md) | [7.5](/filings/0000827054-26-000009.md) | [(13.7) d](/filings/0000827054-26-000016.md) | [2.8](/filings/0000827054-26-000038.md) | [(9.9)](/filings/0000827054-25-000183.md) | [30.9](/filings/0000827054-26-000009.md) | [19.7 d](/filings/0000827054-26-000016.md) | [60.1](/filings/0000827054-26-000038.md) |
| Net income | $m | [667](/filings/0000827054-25-000019.md) | [419](/filings/0000827054-25-000019.md) | [155 d](/filings/0000827054-26-000016.md) | [129](/filings/0000827054-26-000009.md) | [78.4](/filings/0000827054-26-000009.md) | [(53.6)](/filings/0000827054-26-000009.md) | [(155) d](/filings/0000827054-26-000016.md) | [(18.6)](/filings/0000827054-26-000038.md) | [41.7](/filings/0000827054-26-000009.md) | [62.7](/filings/0000827054-26-000009.md) | [144 d](/filings/0000827054-26-000016.md) | [230](/filings/0000827054-26-000038.md) |
| Diluted EPS | $ per share | [1.21](/filings/0000827054-24-000206.md) | [0.77](/filings/0000827054-25-000019.md) | not reported | [0.24](/filings/0000827054-25-000133.md) | [0.14](/filings/0000827054-25-000183.md) | [(0.10)](/filings/0000827054-26-000009.md) | not reported | [(0.09)](/filings/0000827054-26-000038.md) | [0.03](/filings/0000827054-25-000183.md) | [0.06](/filings/0000827054-26-000009.md) | not reported | [0.37](/filings/0000827054-26-000038.md) |
| Basic EPS | $ per share | [1.23](/filings/0000827054-24-000206.md) | [0.78](/filings/0000827054-25-000019.md) | not reported | [0.24](/filings/0000827054-25-000133.md) | [0.15](/filings/0000827054-25-000183.md) | [(0.10)](/filings/0000827054-26-000009.md) | not reported | [(0.09)](/filings/0000827054-26-000038.md) | [0.03](/filings/0000827054-25-000183.md) | [0.06](/filings/0000827054-26-000009.md) | not reported | [0.37](/filings/0000827054-26-000038.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0000827054-23-000185.md) | [0.3](/filings/0000827054-24-000024.md) | [0.3](/filings/0000827054-25-000077.md) | [0.3](/filings/0000827054-24-000139.md) | [0.3](/filings/0000827054-24-000206.md) | [0.6](/filings/0000827054-25-000019.md) | [0.8](/filings/0000827054-26-000016.md) | [0.6](/filings/0000827054-25-000133.md) | [0.2](/filings/0000827054-25-000183.md) | [0.3](/filings/0000827054-26-000009.md) | [0.2](/filings/0000827054-26-000038.md) | [0.3](/filings/0000827054-26-000038.md) |
| Current assets | $bn | [3.5](/filings/0000827054-23-000185.md) | [3.2](/filings/0000827054-24-000024.md) | [3.0](/filings/0000827054-25-000077.md) | [2.9](/filings/0000827054-24-000139.md) | [2.9](/filings/0000827054-24-000206.md) | [3.0](/filings/0000827054-25-000019.md) | [3.0](/filings/0000827054-26-000016.md) | [2.8](/filings/0000827054-25-000133.md) | [2.4](/filings/0000827054-25-000183.md) | [2.3](/filings/0000827054-26-000009.md) | [2.4](/filings/0000827054-26-000038.md) | [2.5](/filings/0000827054-26-000038.md) |
| Total assets | $bn | [16.6](/filings/0000827054-23-000185.md) | [16.1](/filings/0000827054-24-000024.md) | [15.9](/filings/0000827054-25-000077.md) | [15.8](/filings/0000827054-24-000139.md) | [15.6](/filings/0000827054-24-000206.md) | [15.6](/filings/0000827054-25-000019.md) | [15.4](/filings/0000827054-26-000016.md) | [15.0](/filings/0000827054-25-000133.md) | [14.5](/filings/0000827054-25-000183.md) | [14.3](/filings/0000827054-26-000009.md) | [14.4](/filings/0000827054-26-000038.md) | [14.4](/filings/0000827054-26-000038.md) |
| Current liabilities | $bn | [3.4](/filings/0000827054-23-000185.md) | [3.3](/filings/0000827054-24-000024.md) | [2.5](/filings/0000827054-25-000077.md) | [1.5](/filings/0000827054-24-000139.md) | [3.3](/filings/0000827054-24-000206.md) | [1.3](/filings/0000827054-25-000019.md) | [1.2](/filings/0000827054-26-000016.md) | [1.2](/filings/0000827054-25-000133.md) | [1.0](/filings/0000827054-25-000183.md) | [1.1](/filings/0000827054-26-000009.md) | [1.1](/filings/0000827054-26-000038.md) | [1.3](/filings/0000827054-26-000038.md) |
| Long-term debt | $bn | [4.4](/filings/0000827054-23-000185.md) | [4.0](/filings/0000827054-24-000024.md) | [5.0](/filings/0000827054-25-000077.md) | [6.2](/filings/0000827054-24-000139.md) | [4.5](/filings/0000827054-24-000206.md) | [6.7](/filings/0000827054-25-000019.md) | [5.6](/filings/0000827054-26-000016.md) | [5.5](/filings/0000827054-25-000133.md) | [5.4](/filings/0000827054-25-000183.md) | [5.4](/filings/0000827054-26-000009.md) | [5.5](/filings/0000827054-26-000038.md) | [5.4](/filings/0000827054-26-000038.md) |
| Current portion of debt | $bn | [1.7](/filings/0000827054-23-000185.md) | [1.7](/filings/0000827054-24-000024.md) | [1.0](/filings/0000827054-25-000077.md) | [0.0](/filings/0000827054-24-000139.md) | [1.9](/filings/0000827054-24-000206.md) | [0.0](/filings/0000827054-25-000019.md) | [0.0](/filings/0000827054-26-000016.md) | [0.0](/filings/0000827054-25-000133.md) | [0.0](/filings/0000827054-25-000183.md) | [0.0](/filings/0000827054-26-000009.md) | [0.0](/filings/0000827054-26-000038.md) | [0.0](/filings/0000827054-26-000038.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [7.0](/filings/0000827054-25-000019.md) | [7.1](/filings/0000827054-25-000019.md) | [6.7](/filings/0000827054-26-000016.md) | [6.4](/filings/0000827054-26-000009.md) | [6.3](/filings/0000827054-26-000009.md) | [6.0](/filings/0000827054-26-000009.md) | [7.1](/filings/0000827054-26-000038.md) | [6.9](/filings/0000827054-26-000038.md) | [6.7](/filings/0000827054-26-000009.md) | [6.6](/filings/0000827054-26-000009.md) | [6.4](/filings/0000827054-26-000038.md) | [6.5](/filings/0000827054-26-000038.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [616 d](/filings/0000827054-24-000206.md) | [853 d](/filings/0000827054-25-000019.md) | [430 d](/filings/0000827054-26-000016.md) | [377](/filings/0000827054-25-000133.md) | [43.6 d](/filings/0000827054-25-000183.md) | [272 d](/filings/0000827054-26-000009.md) | [206 d](/filings/0000827054-26-000016.md) | [276](/filings/0000827054-26-000038.md) | [88.1 d](/filings/0000827054-25-000183.md) | [341 d](/filings/0000827054-26-000009.md) | [257 d](/filings/0000827054-26-000016.md) | [512](/filings/0000827054-26-000038.md) |
| Capital expenditure | $m | [74.4 d](/filings/0000827054-24-000206.md) | [59.5 d](/filings/0000827054-25-000019.md) | [40.1 d](/filings/0000827054-26-000016.md) | [72.9](/filings/0000827054-25-000133.md) | [20.8 d](/filings/0000827054-25-000183.md) | [18.1 d](/filings/0000827054-26-000009.md) | [14.2 d](/filings/0000827054-26-000016.md) | [17.9](/filings/0000827054-26-000038.md) | [36.5 d](/filings/0000827054-25-000183.md) | [22.5 d](/filings/0000827054-26-000009.md) | [14.2 d](/filings/0000827054-26-000016.md) | [13.9](/filings/0000827054-26-000038.md) |
| Dividends paid | $m | not reported | not reported | not reported | [243](/filings/0000827054-25-000133.md) | [244 d](/filings/0000827054-25-000183.md) | [245 d](/filings/0000827054-26-000009.md) | [245 d](/filings/0000827054-26-000016.md) | [246](/filings/0000827054-26-000038.md) | [246 d](/filings/0000827054-25-000183.md) | [246 d](/filings/0000827054-26-000009.md) | [247 d](/filings/0000827054-26-000016.md) | [247](/filings/0000827054-26-000038.md) |
| Share repurchases | $m | [340 d](/filings/0000827054-24-000206.md) | [115 d](/filings/0000827054-25-000019.md) | [387 d](/filings/0000827054-26-000016.md) | [72.7](/filings/0000827054-25-000133.md) | [17.3 d](/filings/0000827054-25-000183.md) | [6.5 d](/filings/0000827054-26-000009.md) | [0.0 d](/filings/0000827054-26-000016.md) | [0.0](/filings/0000827054-25-000133.md) | [0.0 d](/filings/0000827054-25-000183.md) | [0.0 d](/filings/0000827054-26-000009.md) | [0.0 d](/filings/0000827054-26-000016.md) | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [558](/filings/0000827054-23-000185.md) | [555](/filings/0000827054-24-000024.md) | [551](/filings/0000827054-24-000139.md) | [549](/filings/0000827054-24-000206.md) | [547](/filings/0000827054-25-000019.md) | [543](/filings/0000827054-25-000133.md) | [542](/filings/0000827054-25-000183.md) | [537](/filings/0000827054-26-000009.md) | [539](/filings/0000827054-26-000038.md) | [545](/filings/0000827054-25-000183.md) | [546](/filings/0000827054-26-000009.md) | [551](/filings/0000827054-26-000038.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 543,008,691 at 2026-07-28, from the cover of the [10-Q filed 2026-08-06](/filings/0000827054-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.